Immuron IMRN
NASDAQ IMRN
$0.88 +0.00 (+0.02%)
As of: Nov 10, 2026 · 11:11 AM EST

Immuron (IMRN) Research & Development (2023 - 2024)

Updated

Immuron (IMRN) posted Research & Development of -$1.93 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Research & Development (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Research & Development for 12 fiscal years.

  • Annual Research & Development has run from a low of -$3.6 million in FY2025 to a high of $2.65 million in FY2023 over five years.
  • Business Quant data shows IMRN's Research & Development at -$3.6 million in FY2025, -$53,755 in FY2024, $2.65 million in FY2023 (+74.4%) and $1.52 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 4.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 2.57 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 4.05 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.61 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.02 Bn
10 Immuron 6.54 Mn -21.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.52 Mn
Sep 9, 2024 35,818.58
Dec 31, 2023 16,874.62
API Access

Immuron Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRN&period=max&api_key=YOUR_API_KEY